Results 151 to 160 of about 52,297 (185)

Update of the statement on safety of cannabidiol as a novel food

open access: yesEFSA Journal, Volume 24, Issue 2, February 2026.
Abstract During the assessment of cannabidiol (CBD) as a novel food, in 2022 the NDA Panel identified significant data gaps. Concerns focused on potential adverse effects on the liver, gastrointestinal tract, endocrine, nervous and reproductive systems.
EFSA Panel on Nutrition   +33 more
wiley   +1 more source

Dopamine and serotonin neurotransmissions exert complementary control over primate approach and avoidance. [PDF]

open access: yesTransl Psychiatry
Gauthier L   +10 more
europepmc   +1 more source

Estrogen modulates reward prediction errors and reinforcement learning. [PDF]

open access: yesNat Neurosci
Golden CEM   +9 more
europepmc   +1 more source

ACE2: Friend or Foe in Post-COVID-19 Neurodegeneration? [PDF]

open access: yesInt J Mol Sci
Kononova SV   +4 more
europepmc   +1 more source

Opposite kinetics of L-leucine and L-phenylalanine induced insulin release studies with the perfused rat pancreas [PDF]

open access: yes, 1972
Landgraf, R.   +3 more
core  

Copper, Cuproptosis, and Neurodegenerative Diseases. [PDF]

open access: yesInt J Mol Sci
Genchi G   +4 more
europepmc   +1 more source

Proteomic Exploration of L1CAM<sup>+</sup>-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson's Disease. [PDF]

open access: yesInt J Mol Sci
Xylaki M   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy